BLOG
Hyperkalemia Case Study
In this hyperkalemia case study, I outline the importance of paying attention when medications are discontinued. EN is a 78-year-old female with chronic kidney disease stage 4, hypertension, heart...
Ciprofloxacin With Iron Interaction – Case Study
KE is a 72-year-old female residing in a long-term care facility. She was recently started on ciprofloxacin 500 mg PO BID for a complicated urinary tract infection caused by E. coli. Over the past...
2025 Hypertension Guidelines – 4 Important Takeaways For Pharmacists
The 2025 Hypertension guidelines are out! The alphabet soup of groups that contributed to the guidelines are as follows: AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM - I didn't make...
Long Term Care Problems – Duplicate PRN Anxiety Medications – Case Study
Mrs. H is an 82-year-old resident in a long-term care facility with a history of generalized anxiety disorder, COPD, osteoarthritis, hypertension, insomnia, GERD, and mild cognitive impairment. She...
Iron 2 Tablets Daily – Why This is a Bad Idea
Every so often, you see a medication order that just makes you tilt your head and think, “Huh?” One order that I recently encountered that made me scratch my head was (ferrous sulfate) iron 2...
Case Study – Renal Dose Adjustment and Constipation Polypharmacy
Mrs. M is an 87-year-old female residing in a skilled nursing facility. Her medication list includes: Apixaban 5 mg BID (for atrial fibrillation) Docusate 100 mg BID Senna 8.6 mg BID PEG 17 g daily...
Duplicate Antipsychotics In Hospice – Two Real Life Situations
Here’s a question that comes up in hospice more than you’d think: Why would a hospice patient be on two antipsychotics at the same time? To the average clinician, this raises immediate...
Three Travel Diseases That May Show Up On Your Exam
Many infectious diseases are more prevalent in other areas of the world. In this article, we will cover three important travel diseases along with their prophylaxis and treatment recommendations...
Ertugliflozin – Where Does It Fit in Practice?
Ertugliflozin was first approved in 2017 for the treatment of type 2 diabetes. This medication is an SGLT2 inhibitor that prevents the resorption of glucose back into systemic circulation. It has...
Medications to Avoid in BPH – My Top 4
Benign prostatic hyperplasia (BPH) is one of those conditions that creeps up with age and quietly causes a whole bunch of problems—especially when medications make it worse. A patient might come in...
Study Materials For Pharmacists
